The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery

by Åsa Kristina Öjlert, Ann Rita Halvorsen, Daniel Nebdal, Marius Lund‐Iversen, Steinar Solberg, Odd Terje Brustugun, Ole Christian Lingjærde, Åslaug Helland
Published 2019-05-01

Correction to: A systematic comparison of copy number alterations in four types of female cancer

by Fatemeh Kaveh, Lars O. Baumbusch, Daniel Nebdal, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Hege Edvardsen, Vessela N. Kristensen, Hiroko K. Solvang
Published 2018-01-01

Combining gene signatures improves prediction of breast cancer survival.

by Xi Zhao, Einar Andreas Rødland, Therese Sørlie, Bjørn Naume, Anita Langerød, Arnoldo Frigessi, Vessela N Kristensen, Anne-Lise Børresen-Dale, Ole Christian Lingjærde
Published 2011-01-01

Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors

by Maria Moksnes Bjaanæs, Gro Nilsen, Ann Rita Halvorsen, Hege G. Russnes, Steinar Solberg, Lars Jørgensen, Odd Terje Brustugun, Ole Christian Lingjærde, Åslaug Helland
Published 2021-10-01

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.

by Shay Ben-Elazar, Miriam Ragle Aure, Kristin Jonsdottir, Suvi-Katri Leivonen, Vessela N Kristensen, Emiel A M Janssen, Kristine Kleivi Sahlberg, Ole Christian Lingjærde, Zohar Yakhini
Published 2021-02-01

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

by Evita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, Kristine Kleivi Sahlberg, Vessela N. Kristensen, Daniel Nebdal, Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Olav Engebraaten
Published 2019-10-01

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors

by Inga H. Rye, Anne Trinh, Anna B. Sætersdal, Daniel Nebdal, Ole Christian Lingjærde, Vanessa Almendro, Kornelia Polyak, Anne‐Lise Børresen‐Dale, Åslaug Helland, Florian Markowetz, Hege G. Russnes
Published 2018-11-01

N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome

by Thilde Terkelsen, Vilde D. Haakensen, Radka Saldova, Pavel Gromov, Merete Kjær Hansen, Henning Stöckmann, Ole Christian Lingjærde, Anne‐Lise Børresen‐Dale, Elena Papaleo, Åslaug Helland, Pauline M. Rudd, Irina Gromova
Published 2018-06-01

Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.

by Miriam Ragle Aure, Israel Steinfeld, Lars Oliver Baumbusch, Knut Liestøl, Doron Lipson, Sandra Nyberg, Bjørn Naume, Kristine Kleivi Sahlberg, Vessela N Kristensen, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Zohar Yakhini
Published 2013-01-01

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.

by Anita Sveen, Inger Marie Løes, Sharmini Alagaratnam, Gro Nilsen, Maren Høland, Ole Christian Lingjærde, Halfdan Sorbye, Kaja Christine Graue Berg, Arild Horn, Jon-Helge Angelsen, Stian Knappskog, Per Eystein Lønning, Ragnhild A Lothe
Published 2016-07-01

Artesunate shows potent anti-tumor activity in B-cell lymphoma

by Thea Kristin Våtsveen, Marit Renée Myhre, Chloé Beate Steen, Sébastien Wälchli, Ole Christian Lingjærde, Baoyan Bai, Pierre Dillard, Theodossis A. Theodossiou, Toril Holien, Anders Sundan, Else Marit Inderberg, Erlend B. Smeland, June Helen Myklebust, Morten P. Oksvold
Published 2018-02-01

High levels of genomic aberrations in serous ovarian cancers are associated with better survival.

by Lars O Baumbusch, Åslaug Helland, Yun Wang, Knut Liestøl, Marci E Schaner, Ruth Holm, Dariush Etemadmoghadam, Kathryn Alsop, Pat Brown, Australian Ovarian Cancer Study Group, Gillian Mitchell, Sian Fereday, Anna DeFazio, David D L Bowtell, Gunnar B Kristensen, Ole Christian Lingjærde, Anne-Lise Børresen-Dale
Published 2013-01-01

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

by Jiqiu Cheng, Jonas Demeulemeester, David C. Wedge, Hans Kristian M. Vollan, Jason J. Pitt, Hege G. Russnes, Bina P. Pandey, Gro Nilsen, Silje Nord, Graham R. Bignell, Kevin P. White, Anne-Lise Børresen-Dale, Peter J. Campbell, Vessela N. Kristensen, Michael R. Stratton, Ole Christian Lingjærde, Yves Moreau, Peter Van Loo
Published 2019-01-01

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

by Jiqiu Cheng, Jonas Demeulemeester, David C. Wedge, Hans Kristian M. Vollan, Jason J. Pitt, Hege G. Russnes, Bina P. Pandey, Gro Nilsen, Silje Nord, Graham R. Bignell, Kevin P. White, Anne-Lise Børresen-Dale, Peter J. Campbell, Vessela N. Kristensen, Michael R. Stratton, Ole Christian Lingjærde, Yves Moreau, Peter Van Loo
Published 2017-10-01

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

by Jiqiu Cheng, Jonas Demeulemeester, David C. Wedge, Hans Kristian M. Vollan, Jason J. Pitt, Hege G. Russnes, Bina P. Pandey, Gro Nilsen, Silje Nord, Graham R. Bignell, Kevin P. White, Anne-Lise Børresen-Dale, Peter J. Campbell, Vessela N. Kristensen, Michael R. Stratton, Ole Christian Lingjærde, Yves Moreau, Peter Van Loo
Published 2018-12-01

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

by Elen Kristine Höglander, Silje Nord, David C. Wedge, Ole Christian Lingjærde, Laxmi Silwal-Pandit, Hedda vdL Gythfeldt, Hans Kristian Moen Vollan, Thomas Fleischer, Marit Krohn, Ellen Schlitchting, Elin Borgen, Øystein Garred, Marit M. Holmen, Erik Wist, Bjørn Naume, Peter Van Loo, Anne-Lise Børresen-Dale, Olav Engebraaten, Vessela Kristensen
Published 2018-11-01

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer

by Robert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, Valeria Vitelli, Torill Sauer, Jürgen Geisler, Solveig Hofvind, Elin Borgen, Anne-Lise Børresen-Dale, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry Aarum Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild Mari Mælandsmo, Hege G. Russnes, Ellen Schlichting, Therese Sørlie, Ole Christian Lingjærde, Vessela Kristensen, Kristine Kleivi Sahlberg, Helle Kristine Skjerven, Britt Fritzman
Published 2016-07-01

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

by Miriam Ragle Aure, Valeria Vitelli, Sandra Jernström, Surendra Kumar, Marit Krohn, Eldri U. Due, Tonje Husby Haukaas, Suvi-Katri Leivonen, Hans Kristian Moen Vollan, Torben Lüders, Einar Rødland, Charles J. Vaske, Wei Zhao, Elen K. Møller, Silje Nord, Guro F. Giskeødegård, Tone Frost Bathen, Carlos Caldas, Trine Tramm, Jan Alsner, Jens Overgaard, Jürgen Geisler, Ida R. K. Bukholm, Bjørn Naume, Ellen Schlichting, Torill Sauer, Gordon B. Mills, Rolf Kåresen, Gunhild M. Mælandsmo, Ole Christian Lingjærde, Arnoldo Frigessi, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Kristine K. Sahlberg, OSBREAC
Published 2017-03-01

Breast cancer quantitative proteome and proteogenomic landscape

by Henrik J. Johansson, Fabio Socciarelli, Nathaniel M. Vacanti, Mads H. Haugen, Yafeng Zhu, Ioannis Siavelis, Alejandro Fernandez-Woodbridge, Miriam R. Aure, Bengt Sennblad, Mattias Vesterlund, Rui M. Branca, Lukas M. Orre, Mikael Huss, Erik Fredlund, Elsa Beraki, Øystein Garred, Jorrit Boekel, Torill Sauer, Wei Zhao, Silje Nord, Elen K. Höglander, Daniel C. Jans, Hjalmar Brismar, Tonje H. Haukaas, Tone F. Bathen, Ellen Schlichting, Bjørn Naume, Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Torben Luders, Elin Borgen, Vessela N. Kristensen, Hege G. Russnes, Ole Christian Lingjærde, Gordon B. Mills, Kristine K. Sahlberg, Anne-Lise Børresen-Dale, Janne Lehtiö
Published 2019-04-01